Featured Research

from universities, journals, and other organizations

Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks

Date:

August 27, 2014

Source:

American Chemical Society

Summary:

Ebola is a rare, but deadly disease that exists as five strains, none of which have approved therapies. One of the most lethal strains is the Sudan ebolavirus (SUDV). Although not the strain currently devastating West Africa, SUDV has caused widespread illness, even as recently as 2012. Researchers now report a possible therapy that could someday help treat patients infected with SUDV.

Share This

Ebola is a rare, but deadly disease that exists as five strains, none of which have approved therapies. One of the most lethal strains is the Sudan ebolavirus (SUDV). Although not the strain currently devastating West Africa, SUDV has caused widespread illness, even as recently as 2012. In a new study appearing in the journal ACS Chemical Biology, researchers now report a possible therapy that could someday help treat patients infected with SUDV.

Related Articles

John Dye, Sachdev Sidhu, Jonathan Lai and colleagues explain that about 50-90 percent of ebola patients die after experiencing the typical symptoms of the disease, which include fever, muscle aches, vomiting and bleeding. Of the five known ebolaviruses, the Zaire (EBOV) and SUDV strains are the most deadly and cause the most recurring outbreaks. Many studies have focused on EBOV, the culprit of the current epidemic, but much less attention has been placed on SUDV until now. To develop a therapy for SUDV, this research team turned to an antibody that Dye's group previously reported. The team's antibody was directed against SUDV and was made in mice. But the human immune system could potentially recognize that antibody as foreign and ultimately get rid of it, preventing the antibody from treating the disease. To avoid this situation, they wanted to make a "humanized" version of the antibody.

In the newly published work, the team put the ebola-specific part of the mouse antibody onto a human antibody scaffold and made some changes to this molecule. They identified two versions that were able to fend off SUDV in laboratory tests on cells and in specially bred mice. "These antibodies represent strong immunotherapeutic candidates for the treatment of SUDV infection," say the researchers.

This research, however, isn't expected to help with the current ebola outbreak that, as of mid-August, has killed at least 1,200 people. That's because antibodies that kill off one strain of the virus haven't worked against other strains. The U.S. Food and Drug Administration -- which has not yet approved any ebola therapies -- did allow two U.S. aid workers infected during the current outbreak to be treated with an experimental drug, which is a cocktail of antibodies specifically targeting EBOV.

The authors acknowledge funding from the National Institutes of Health, the Canadian Institutes for Health Research and the Defense Threat Reduction Agency.

American Chemical Society. "Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks." ScienceDaily. ScienceDaily, 27 August 2014. <www.sciencedaily.com/releases/2014/08/140827111942.htm>.

American Chemical Society. (2014, August 27). Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks. ScienceDaily. Retrieved March 3, 2015 from www.sciencedaily.com/releases/2014/08/140827111942.htm

American Chemical Society. "Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks." ScienceDaily. www.sciencedaily.com/releases/2014/08/140827111942.htm (accessed March 3, 2015).

More From ScienceDaily

More Health & Medicine News

Featured Research

Mar. 3, 2015 — Scientists have discovered a new hormone that fights the weight gain caused by a high-fat Western diet and normalizes the metabolism -- effects commonly associated with exercising. When tested in ... full story

Mar. 3, 2015 — New assays can detect malaria parasites in human blood at very low levels and might be helpful in the campaign to eradicate malaria, reports a new study. An international team led by Ingrid Felger, ... full story

Mar. 3, 2015 — Adults over the age of 30 only catch flu about twice a decade, a new study suggests. So, while it may feel like more, flu-like illness can be caused by many pathogens, making it difficult to assess ... full story

Mar. 3, 2015 — No significant change in home habits of smokers have been observed in the aftermath of a ban on smoking in public spaces, researchers report. Greater inspiration to kick the habit likely comes from ... full story

Mar. 3, 2015 — Heart function has been associated with the development of dementia and Alzheimer's disease through a new study. Participants with decreased heart function, measured by cardiac index, were two to ... full story

Mar. 3, 2015 — Children of recently separated or divorced families are likelier to drink sugar-sweetened beverages than children in families where the parents are married, putting them at higher risk for obesity ... full story

Mar. 3, 2015 — Gastric bypass and similar stomach-shrinking surgeries are a popular option for obese patients looking to lose weight or treat type 2 diabetes. While the surgeries have been linked to a decreased ... full story

Mar. 3, 2015 — Most people consume more salt than they need and therefore have a higher risk of heart disease and stroke, which are the two leading causes of death worldwide. But a new study reveals that dietary ... full story

Featured Videos

Mom Triumphs Over Tragedy, Helps Other Families

AP (Mar. 3, 2015) — After her son, Dax, died from a rare form of leukemia, Julie Locke decided to give back to the doctors at St. Jude Children&apos;s Research Hospital who tried to save his life. She raised $1.6M to help other patients and their families. (March 3)
Video provided by AP

Looted and Leaking, South Sudan's Oil Wells Pose Health Risk

AFP (Mar. 3, 2015) — Thick black puddles and a looted, leaking ruin are all that remain of the Thar Jath oil treatment facility, once a crucial part of South Sudan&apos;s mainstay industry. Duration: 01:13
Video provided by AFP

Woman Convicted of Poisoning Son

AP (Mar. 3, 2015) — A woman who blogged for years about her son&apos;s constant health woes was convicted Monday of poisoning him to death by force-feeding heavy concentrations of sodium through his stomach tube. (March 3)
Video provided by AP

Related Stories

Jan. 21, 2015 — Researchers have determined why Ebola virus becomes increasingly lethal as it jumps species. The research team looked at the Zaire Ebola strain in an animal system to understand how it gains ... full story

Sep. 9, 2014 — The effort to develop therapeutics and a vaccine against the deadly Ebola virus disease (EVD) requires a complex understanding of the microorganism and its relationship within the host, especially ... full story

Aug. 29, 2014 — A leading US Ebola researcher has gone on record stating that a blend of three monoclonal antibodies can completely protect monkeys against a lethal dose of Ebola virus up to five days after ... full story

Aug. 28, 2014 — A potential antibody therapy for Sudan ebolavirus (SUDV), one of the two most lethal strains of Ebola, has been developed by researchers. A different strain, the Zaire ebolavirus (EBOV), is now ... full story

Aug. 6, 2014 — Two birds with one stone: A novel and broad Ebola vaccine in humans or with specially engineered cows could help researchers develop large quantities of Anti-Ebola serum and protect humans against ... full story

ScienceDaily features breaking news and videos about the latest discoveries in health, technology, the environment, and more -- from major news services and leading universities, scientific journals, and research organizations.